Note: This article is written for general informational and publishing purposes. It discusses public legal developments and is not legal advice.
The Eleventh Circuit has stepped into one of the most consequential False Claims Act fights in decades: whether private whistleblowers can constitutionally sue on behalf of the United States through the statute’s famous qui tam provision. That may sound like a niche legal debate designed to make law students stare into the middle distance, but the stakes are anything but tiny. We are talking about Medicare fraud cases, defense contractor disputes, government procurement claims, whistleblower rewards, executive power, and the future of one of the federal government’s most productive anti-fraud tools.
The appeal centers on United States ex rel. Zafirov v. Florida Medical Associates, a case that began as a healthcare fraud lawsuit and turned into a constitutional showdown. In September 2024, a federal district judge in Florida held that the False Claims Act’s qui tam mechanism violates Article II of the Constitution because it allows private individuals to exercise executive power without being properly appointed as officers of the United States. The United States and the relator appealed, and the Eleventh Circuit heard argument on December 12, 2025.
That oral argument did not produce fireworks in the television-drama sense. No one shouted “objection” while dramatically pointing at a marble column. But in appellate-law terms, it was a big deal. The judges tested both sides on the Appointments Clause, the Take Care Clause, historical practice, government control over litigation, and what would happen if the court agrees that qui tam relators have been constitutionally awkward houseguests for more than a century.
What Is a Qui Tam Lawsuit?
A qui tam lawsuit allows a private person, known as a relator, to sue on behalf of the government. The phrase comes from Latin, because apparently lawyers once looked at ordinary English and thought, “Not confusing enough.” In the False Claims Act context, a relator alleges that a person or company defrauded the federal government. If the case succeeds, the relator may receive a share of the recovery, typically ranging from 15% to 30%, depending on whether the government intervenes and other case-specific factors.
The False Claims Act was originally enacted during the Civil War to combat fraud by contractors selling defective goods to the Union Army. Over time, especially after major amendments in 1986, it became a central weapon against fraud involving Medicare, Medicaid, defense contracts, government grants, pandemic-relief programs, and other federal spending. When people call it the government’s “anti-fraud workhorse,” they are not being dramatic. The statute has produced tens of billions of dollars in recoveries since the modern amendments took effect.
The qui tam structure is simple in theory. A whistleblower files a complaint under seal. The government investigates and decides whether to intervene. If the government intervenes, it takes primary control. If it declines, the relator may continue the lawsuit in the name of the United States. That last part is where the constitutional debate begins to heat up.
The Zafirov Case: From Medicare Allegations to Article II
The Zafirov case began with Dr. Clarissa Zafirov, who alleged that Florida Medical Associates and related defendants misrepresented patient conditions in connection with Medicare reimbursement. The United States declined to intervene, meaning Zafirov continued the case as a private relator. The defendants later argued that allowing her to pursue claims on behalf of the United States violated Article II of the Constitution.
The district court agreed. Judge Kathryn Kimball Mizelle of the Middle District of Florida ruled that FCA relators exercise significant executive power because they can initiate and control litigation in the name of the United States. In the court’s view, that made them officers of the United States. Because relators are not appointed by the President, a department head, or a court of law, the court concluded that the qui tam provisions violate the Appointments Clause.
That ruling was extraordinary because federal courts had repeatedly upheld the False Claims Act’s qui tam structure in earlier challenges. For years, the constitutional debate existed mostly as an academic and defense-bar argument: interesting, persistent, and usually unsuccessful. Zafirov changed the mood. Suddenly, the argument had a district court victory, an appeal in a major federal circuit, and enough momentum to make Supreme Court watchers reach for their binoculars.
Why the Eleventh Circuit Appeal Matters
The Eleventh Circuit appeal matters because it could become the first federal appellate decision in this new wave of Article II challenges to directly confront the modern constitutionality of the FCA’s qui tam provisions after the Supreme Court’s recent separation-of-powers cases. If the Eleventh Circuit reverses, the traditional view survives, at least for now. If it affirms, the result could create a serious circuit conflict or accelerate Supreme Court review.
The issue is not merely whether one whistleblower can proceed with one Medicare fraud case. The question is whether Congress may authorize private citizens to litigate claims in the government’s name when the Executive Branch has declined to take over the case. Critics say that is executive enforcement power, and executive power must remain accountable to the President. Defenders say relators are private litigants with a partial assignment of the government’s claim, subject to meaningful government oversight.
In practical terms, the appeal affects companies facing FCA exposure, whistleblowers considering whether to file, healthcare providers trying to assess risk, compliance officers updating internal controls, and government lawyers defending a statute that has returned massive sums to the Treasury. In other words, this is not just a constitutional-law seminar. It is also a compliance department’s group chat becoming very active at 8:03 a.m.
The Constitutional Arguments Against Qui Tam
1. The Appointments Clause Argument
The Appointments Clause says that officers of the United States must be appointed through constitutionally specified methods. The challengers argue that FCA relators qualify as officers because they exercise significant authority under federal law. They file suit in the name of the United States, pursue claims that belong to the government, conduct discovery, negotiate litigation strategy, and potentially force defendants into costly proceedings.
From that perspective, a relator is not merely a private plaintiff seeking a personal remedy. The relator is wielding federal enforcement authority. If that authority is executive in nature, the argument goes, it cannot be handed to a self-selected private party who was not appointed, confirmed, supervised, or removable in the usual constitutional sense.
2. The Take Care Clause Argument
The Take Care Clause requires the President to ensure that the laws are faithfully executed. Critics of qui tam say the statute interferes with that duty by allowing private relators to continue litigation even when the Executive Branch has chosen not to intervene. Although the government retains certain rights, such as receiving filings, seeking dismissal, or intervening later for good cause, challengers argue that these tools do not provide enough control.
The concern is accountability. If a private relator makes aggressive litigation choices in the government’s name, who answers for those choices? Not the President. Not a Senate-confirmed official. Not necessarily even a DOJ attorney. Critics say that arrangement leaves federal power floating around without a proper constitutional leash.
3. The Vesting Clause Argument
Some challengers also invoke Article II’s Vesting Clause, which vests executive power in the President. Under this theory, Congress cannot transfer core executive enforcement authority to private individuals. Even if relators are not technically “officers,” the argument continues, they still perform functions that belong to the Executive Branch.
This argument has gained more attention because the Supreme Court has recently shown renewed interest in separation-of-powers boundaries. The Court’s modern doctrine has emphasized presidential control over executive actors in several contexts, and FCA defendants have taken notice. Defense lawyers are not famous for missing helpful constitutional breadcrumbs.
The Arguments Defending Qui Tam
1. Relators Are Private Parties, Not Federal Officers
Supporters of qui tam constitutionality argue that relators are not officers of the United States because they do not hold a federal office. They are private litigants pursuing a statutory cause of action. They do not bind the government through final agency action, issue regulations, prosecute crimes, command federal employees, or spend federal funds. They litigate a civil case and may receive a financial award if the case succeeds.
This distinction matters. If every private person authorized by statute to vindicate public interests became a federal officer, many familiar legal arrangements could become constitutionally suspicious. Citizen suits, private attorney general statutes, and statutory enforcement schemes could all face uncomfortable questions.
2. The Government Keeps Important Control
The United States argues that the FCA gives the Executive Branch meaningful authority over qui tam litigation. The government receives the complaint under seal, investigates before intervention decisions, may intervene later with court approval, may seek dismissal, may settle over a relator’s objection subject to judicial review, and receives the bulk of any recovery.
Defenders say that this oversight is enough to preserve executive control. The relator may drive the car when the government declines to intervene, but the government still owns the road, the map, and several emergency brake options. Whether that metaphor survives strict constitutional analysis is exactly what the Eleventh Circuit must decide.
3. History Supports Qui Tam Actions
Historical practice is a major piece of the defense. Qui tam actions existed in English law and appeared in early American statutes. Congress has used private enforcement mechanisms since the founding era, and supporters argue that this history strongly suggests the practice is compatible with Article II.
The challengers respond that historical examples were narrower, different in structure, or not enough to justify the modern FCA’s powerful litigation scheme. That debate turns history into a legal tug-of-war: one side says tradition confirms constitutionality, while the other says modern qui tam litigation has outgrown its historical shoes.
The Shadow of Polansky
The Supreme Court’s 2023 decision in United States ex rel. Polansky v. Executive Health Resources did not decide whether qui tam suits are constitutional. The majority addressed the government’s authority to dismiss FCA cases after initially declining to intervene. But the separate opinions made the constitutional issue much harder to ignore.
Justice Clarence Thomas raised serious questions about whether the qui tam device is consistent with Article II. Justice Brett Kavanaugh, joined by Justice Amy Coney Barrett, wrote separately to say that the constitutional issues warrant consideration in an appropriate case. That was not a final answer, but it was enough to make defendants across the country circle the issue in red ink.
Zafirov may be the kind of case that tests whether those questions were a passing judicial footnote or a preview of a much larger shift. The Eleventh Circuit panel appeared aware that whatever it decides may not be the final chapter. The Supreme Court may eventually have to resolve whether the FCA’s whistleblower model can coexist with the Court’s current Article II doctrine.
What Happened at the Eleventh Circuit Argument?
At oral argument, the Eleventh Circuit questioned the parties closely about the source and scope of relator authority. The judges explored whether a relator is best understood as an officer, an assignee, a private plaintiff, or something stranger that wandered out of a Civil War statute and into modern constitutional doctrine.
The government defended the FCA by emphasizing executive oversight and historical acceptance. Zafirov’s counsel argued that relators do not exercise the kind of sovereign authority that would make them officers. The defendants countered that relators prosecute claims belonging to the United States and may do so for years without direct presidential supervision.
One recurring question was control. How much control must the Executive Branch have for the arrangement to be constitutional? Is the power to intervene, dismiss, or settle enough? Or does the Constitution require day-to-day supervision of anyone litigating in the government’s name? The answer could shape not only FCA practice but also broader debates over private enforcement of public rights.
Possible Outcomes of the Appeal
Outcome One: The Eleventh Circuit Reverses
The court could reverse the district court and uphold the qui tam provisions. That would align with earlier appellate decisions that have rejected constitutional attacks on the FCA. It would also preserve the status quo for whistleblower litigation in the Eleventh Circuit, covering Alabama, Florida, and Georgia.
A reversal would not end the national debate. Defendants could still ask the Supreme Court to review the case, especially because several justices have already expressed interest. But a reversal would make the path less dramatic than an appellate decision striking down part of the FCA.
Outcome Two: The Eleventh Circuit Affirms
If the Eleventh Circuit affirms, the result would be explosive in the calm, footnote-heavy way appellate law can be explosive. It could jeopardize non-intervened qui tam cases within the circuit and encourage similar challenges nationwide. It would also create enormous pressure for Supreme Court review.
An affirmance could raise difficult remedy questions. Would the court invalidate the entire qui tam mechanism? Only non-intervened cases? Only the relator-control provisions? Could the defect be cured by greater government supervision? These are not small questions. They are the kind of questions that make litigators pretend to enjoy flowcharts.
Outcome Three: A Narrow Procedural Decision
The court might avoid the broadest constitutional ruling by deciding the case on narrower grounds. Courts often prefer narrow paths when the alternative is detonating a major federal statute. A limited ruling could address standing, remedy, waiver, severability, or the specific posture of the Zafirov litigation without resolving every Article II issue.
That approach would delay, not eliminate, the constitutional fight. Similar challenges are already appearing in other courts, and FCA defendants have strong incentives to keep pressing the argument.
Why Businesses Are Watching Closely
Businesses that contract with the federal government or receive federal funds are watching Zafirov because FCA exposure can be severe. The statute allows treble damages and civil penalties, and litigation costs can be substantial even before liability is decided. Healthcare companies, defense contractors, universities, technology vendors, grant recipients, and financial institutions all operate in spaces where FCA claims can arise.
If qui tam litigation becomes constitutionally limited, defendants may gain a powerful new tool in non-intervened cases. Motions to dismiss based on Article II could become routine, at least until the Supreme Court provides clarity. Companies facing FCA complaints would likely examine whether the government intervened, how much control DOJ exercised, and whether the relator’s authority resembles the kind of executive power criticized in Zafirov.
That said, companies should not treat the appeal as a free pass to loosen compliance programs. Even if the qui tam provision were narrowed, the government could still bring FCA cases directly. State false claims acts, criminal statutes, administrative remedies, contract actions, and exclusion risks would remain. Fraud risk does not vanish just because constitutional law enters the chat wearing a powdered wig.
Why Whistleblowers Are Watching Closely
Whistleblowers are watching for obvious reasons. The qui tam provision gives insiders a path to report fraud and share in recoveries when the government succeeds. Without that mechanism, some fraud might never come to light, especially in complex industries where misconduct can be hidden inside billing codes, reimbursement formulas, procurement documents, or technical certifications.
If courts restrict non-intervened qui tam suits, relators may depend more heavily on government intervention. That could make early case presentation even more important. Whistleblowers and their attorneys would need to provide clear evidence, credible damages theories, and practical explanations of why the government should invest resources in the case.
At the same time, even a ruling against the current structure might not end whistleblower enforcement. Congress could revise the statute to increase executive control, adjust appointment procedures, or redesign the relator role. The hard part would be preserving the incentives that make whistleblowers come forward while satisfying constitutional limits.
The Bigger Separation-of-Powers Debate
Zafirov is part of a larger legal movement focused on presidential control, agency authority, and private enforcement. In recent years, the Supreme Court has shown increased interest in the structure of government power: who exercises it, who supervises it, and who can be held accountable when it is misused.
The qui tam debate fits neatly into that trend. Supporters see relators as a historically grounded anti-fraud partnership between citizens and the government. Opponents see them as private prosecutors wielding federal power without constitutional appointment or removal. Both descriptions contain enough truth to make the case genuinely difficult.
The Eleventh Circuit’s decision may therefore become more than an FCA ruling. It may become a marker in the continuing battle over how much enforcement authority Congress may place outside direct executive control. That is why legal observers expect the issue to keep moving upward, possibly to the Supreme Court.
Practical Examples: How the Ruling Could Play Out
Consider a Medicare Advantage coding case. A physician or former employee alleges that a provider inflated diagnosis codes to increase reimbursement. The government investigates but declines to intervene. Under the current FCA model, the relator may continue. If Zafirov is affirmed broadly, the defendant may argue that the relator cannot continue because doing so would be an unconstitutional exercise of executive power.
Now consider a defense contractor case. An engineer alleges that a contractor knowingly supplied nonconforming parts to the government. The government may decline intervention because of limited resources, competing priorities, or uncertainty about proof. If private relator authority is restricted, that case may never proceed unless DOJ takes it over.
Finally, think about a university grant case. A researcher alleges that federal grant conditions were knowingly misrepresented. If the government declines, the relator’s ability to proceed may depend on whether courts treat the case as private litigation based on an assigned claim or public enforcement requiring executive appointment.
These examples show why the constitutional label matters. The same lawsuit can look very different depending on whether the relator is viewed as a private claimant, a partial assignee, a public enforcer, or an unappointed officer.
Experiences and Lessons From the Qui Tam Constitutionality Fight
One practical experience from watching FCA litigation is that constitutional arguments often start as “long shots” before becoming standard operating procedure. For years, many defendants raised Article II concerns about qui tam suits with limited success. Courts generally relied on precedent, history, and the government’s oversight powers to uphold the statute. But legal arguments are a little like software updates: sometimes the same code behaves differently after the system changes. Recent Supreme Court separation-of-powers decisions gave the old qui tam argument a new operating environment.
Another lesson is that FCA cases rarely involve only abstract legal theory. Behind the constitutional debate are real compliance systems, billing practices, audit trails, medical records, contract certifications, and internal emails that someone probably wishes had been written with less enthusiasm. In healthcare cases, alleged misconduct may involve diagnosis coding, medical necessity, kickbacks, or reimbursement rules. In defense and procurement cases, it may involve product quality, pricing, cybersecurity promises, or country-of-origin requirements. The constitutional question determines who may prosecute the claim, but the factual foundation still determines whether the claim has teeth.
For companies, the experience of Zafirov should reinforce the value of strong internal reporting channels. If employees believe their concerns are ignored, they may look outside the company. A well-run compliance program can investigate concerns early, document decisions, correct errors, and reduce the chance that a dispute becomes a sealed federal lawsuit. That does not mean every internal complaint is valid. It means every credible complaint deserves a serious process. The cheapest FCA case is usually the one prevented by boring but effective compliance work.
For whistleblowers, the experience is different. The Zafirov appeal highlights the importance of evidence quality. A relator who wants the government to intervene must present more than suspicion. Strong cases usually include documents, firsthand knowledge, clear timelines, reliable witnesses, and a realistic damages theory. The more uncertain the constitutional future of non-intervened cases becomes, the more important government intervention may be. That means the initial disclosure package and cooperation with investigators can matter enormously.
For lawyers, Zafirov is a reminder that remedies matter. If a court finds a constitutional problem, what happens next? Does the case get dismissed? Can the government intervene and cure the defect? Are past settlements vulnerable? Are relator shares affected? Can Congress amend the statute? A constitutional ruling is not the end of the analysis; it is often the beginning of a messy remedial puzzle. Anyone who says the answer is simple may be selling confidence by the gallon.
The human experience of this issue is also worth remembering. Whistleblower cases can take years. Defendants may face reputational harm and massive expense. Relators may risk careers, relationships, and financial stability. Government lawyers must choose which cases deserve public resources. Courts must balance history, text, precedent, and constitutional structure. In that sense, the Eleventh Circuit appeal is not just about whether a Latin phrase survives Article II scrutiny. It is about how the legal system channels fraud allegations when public money is at stake.
The best takeaway is balanced: no one should assume qui tam is dead, and no one should assume it is untouchable. The False Claims Act remains a powerful statute, but its private-enforcement model is facing the most serious constitutional test it has seen in modern times. Until appellate courts and perhaps the Supreme Court provide a definitive answer, the smart move for businesses is to strengthen compliance, for whistleblowers to build evidence carefully, and for lawyers to keep both their constitutional arguments and their practical case strategies ready.
Conclusion
The Eleventh Circuit’s review of qui tam constitutionality in Zafirov places the False Claims Act at a crossroads. On one side is a long-standing enforcement model that has helped the government recover billions from fraud. On the other side is a serious Article II challenge arguing that private relators exercise executive power without proper appointment, supervision, or accountability.
Whatever the Eleventh Circuit decides, the dispute is unlikely to disappear. The constitutional questions raised by Zafirov are already spreading to other courts, and Supreme Court interest seems increasingly plausible. For now, the case is a must-watch for healthcare providers, government contractors, compliance officers, whistleblowers, and anyone who enjoys separation-of-powers debates with real financial consequences.
The qui tam system has survived wars, amendments, corporate scandals, healthcare fraud waves, and enough litigation to fill a small warehouse. Whether it can survive this Article II challenge may define the next era of False Claims Act enforcement.